The FDA has stem cell clinics squarely on its radar screen now and it’s pulling the trigger with many letters going out to this problematic industry. In the past, sometimes years went by with no letters at all or one letter in total to stem cell clinics so this marks a major shift. Background on […]
Historic spring storm of FDA letters to stem cell clinic industry Read More »
The Niche has had many authors over the years, focusing on expertise in the biomedical arena and in particular related to stem cells. I’ve invited many authorities in particular areas to write posts. Over the years I’ve written probably 99+% of the posts here on The Niche, but we’ve also had some great guest authors
Authors on The Niche Read More »
There is always plenty of complicated, mixed-bag news on the stem cell and regenerative medicine front so it’s great to highlight when there’s some good news out there. Today’s post includes several such upbeat items. At the bottom I’ve included a list of some recent interesting publications as well. Good news on vision front: jCyte
Stem cell & regenerative medicine good news & pubs Read More »
How can we scientists find ways to keep doing our research during the COVID19 pandemic even if it has nothing to do with the coronavirus? Also, how should those of us involved in science communication talk about the outbreak? At a more basic level, how can scientists try not to go bonkers during this dark
Scientists try not to lose it with their labs shut by the pandemic Read More »
We kind of take for granted these days that embryonic stem cell research can proceed without any restrictions, at least at the federal level. However, in the early days of blogging here on The Niche the big debate and battle were over federal funding of embryonic stem cell research. Things got very complicated and for
Lessons from when embryonic stem cell research was illegal Read More »
The California Stem Cell Agency, better known by the acronym CIRM, has done a vast amount of good over the past decade and a half, and today it needs your help for the future. CIRM, which stands for the “California Institute for Regenerative Medicine”, has funded a huge array of stem cell and other research
Please take a couple minutes now to help fund future of CIRM Read More »
Texas Governor Greg Abbott has effectively banned abortions in his state during the COVID-19 pandemic, but his reasoning makes no sense and is inconsistent with his policies more generally on health-care clinics. The Tribune notes that while “Abbott’s original ban was intended to preserve medical resources”, his own statements contradict that, including “On Friday, he
Texas Gov Abbott pandemic hypocrisy on abortion vs. stem cell clinics Read More »
When the number of stem cell clinical studies and trials listed for COVID-19 first started spiraling upward it seemed likely that stem cell clinics and other firms in that arena would get interested. I thought that we’d see the unproven regenerative medicine coronavirus bandwagon quickly grow. Unfortunately, there are reasons to be increasingly concerned here. For instance,
As clinics buzz about coronavirus, COVID19 patient given non-FDA-approved exosomes? Read More »
Should we call it stem cell synchronicity for stem cell supplier firm Invitrx? What was it about March 16? Sometimes strange things happen in the stem cell world such as last week on March 16 I wrote that the FDA needs to do more about unproven exosomes, and then on the same day a new FDA warning
‘Captain Kirk’ regenerative clinic supplier Invitrx gets long FDA warning letter Read More »
The FDA needs to do more about clinics and suppliers of unproven “exosome therapies.” Dubious exosomes are sadly just the newest gimmick for some firms in the stem cell/regenerative medicine clinic arena right now. They are available at many stem cell and other clinics right now, but who knows what’s in the syringe? Also, people
FDA needs to act boldly on unproven exosome therapies Read More »